ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Phase II Study of Myeloablative 8/8- or 7/8-Matched AlloSCT With Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
By
ASH 2022 Conference Coverage
FEATURING
Alex Hoover
By
ASH 2022 Conference Coverage
FEATURING
Alex Hoover
21 views
December 28, 2022
Login to view comments.
Click here to Login
Leukemia